ELAVL1 and metabolic dysfunction-associated steatotic liver disease: Conversely, the AUBP HuR, which competes with TTP for the binding to several mRNA targets, exerts an opposite function in MASLD, as evidenced in liver-specific HuR KO mice, which develop hepatic steatosis and fibrosis [171,172].